The Fluoxetine Capsules, cataloged under National Stock Number 6505-01-397-4313, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Teva Pharmaceuticals Usa, Inc.. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-397-4313 |
| Primary Part Number | NDC50111-0647-01 |
| Item Name | Fluoxetine Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Teva Pharmaceuticals Usa, Inc. |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 100.000 |
| Active Medicament Medicinal Strength | 10.000 MILLIGRAMS FLUOXETINE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC50111-0647-01 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| NDC00777-3104-02 | Eli Lilly and Company (USA) |
| NDC77771-0113-01 PRIMARY | Radha Pharmaceuticals Inc (USA) |
NSN 6505-01-397-4313 is a Fluoxetine Capsules, manufactured by Teva Pharmaceuticals Usa, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-397-4313 has 3 manufacturer part numbers on file: NDC50111-0647-01 (Teva Pharmaceuticals Usa, Inc.), NDC00777-3104-02 (Eli Lilly and Company), NDC77771-0113-01 (Radha Pharmaceuticals Inc).
Key specifications for NDC50111-0647-01: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 100.000; Part Name Assigned by Controlling Agency: FLUOXETINE HYDROCHLORIDE CAPSULES 10MG 100S BT. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.